HIF1A and neoplasm: Alternatively, the use of special microcarriers on the basis of liposomes or nanoparticles or dendrimers containing pharmacological inhibitors of HIF-1 or oligonucleotide vectors downregulating the HIF-1α expression may be an effectual way to suppress HIF-1 inside hypoxic tumor cells.